Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Feb 29, 2024 $53.68 $54.39 $51.69 $51.72 1 056 467
Feb 28, 2024 $53.66 $54.48 $52.58 $52.75 915 441
Feb 27, 2024 $50.97 $53.90 $50.73 $53.66 885 982
Feb 26, 2024 $49.43 $50.71 $49.09 $50.25 535 612
Feb 23, 2024 $48.78 $50.20 $48.75 $49.48 454 394
Feb 22, 2024 $48.00 $49.36 $47.49 $48.88 395 353
Feb 21, 2024 $47.96 $48.53 $47.68 $48.18 440 254
Feb 20, 2024 $48.47 $49.73 $47.29 $47.87 652 274
Feb 16, 2024 $47.00 $49.57 $46.58 $48.92 1 064 837
Feb 15, 2024 $46.32 $47.08 $45.82 $46.26 843 392
Feb 14, 2024 $44.64 $45.93 $44.42 $45.66 583 454
Feb 13, 2024 $45.39 $45.39 $43.69 $43.98 584 204
Feb 12, 2024 $46.90 $47.82 $46.46 $46.74 578 806
Feb 09, 2024 $45.22 $47.13 $45.17 $46.73 431 969
Feb 08, 2024 $44.82 $45.66 $44.79 $45.45 652 514
Feb 07, 2024 $45.87 $45.91 $44.59 $44.71 496 169
Feb 06, 2024 $45.06 $45.96 $44.45 $45.89 704 924
Feb 05, 2024 $42.62 $44.98 $42.37 $44.76 702 362
Feb 02, 2024 $43.79 $43.79 $42.62 $43.02 606 475
Feb 01, 2024 $44.49 $44.71 $43.65 $44.10 672 103
Jan 31, 2024 $44.88 $45.61 $43.68 $44.11 551 277
Jan 30, 2024 $46.21 $46.21 $44.44 $44.88 473 994
Jan 29, 2024 $45.14 $46.48 $44.33 $45.99 699 200
Jan 26, 2024 $45.50 $45.96 $44.82 $44.97 537 740
Jan 25, 2024 $44.14 $45.32 $44.00 $45.25 680 898
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT